Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
1 "This submission reflects the continued advancement of Novo Nordisk's obesity pipeline and our focus on translating scientific innovation into patient-relevant outcomes
.jpg)
Lysosomal iron content of human tumour samples and healthy adjacent tissues was analysed with the following antibody and stain panel: DAPI (0.1 g ml 1 ), CD3-BV510 (BioLegend, 317332), CD31-PE-Cy7 (BioLegend, 303118), CD44-AF647 (Novus Biologicals, NB500-481AF647), CD45-BV785 (BioLegend, 304048), CD163-PerCP/Cyanine5.5 (BioLegend, 326512), FAP-AF700 (R&D Systems, FAB3715N) and TFR1-APC-AF750 (Beckman Coulter, A89313)
When reconstitution goes right: what to expect from proper tirzepatide protocols Accurate reconstitution is the foundation, but it is not the goal
(2018) Ferroptosis: a novel anti-tumor action for cisplatin, Cancer Res
US$ 21.67
US$ 27.28
US$ 20.37
US$ 28.35
US$ 27.77
US$ 25.81
